Ingliforib

Ingliforib (CP 368296) is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.

Product Specifications

CAS Number

[186392-65-4]

Product Name Alternative

CP 368296; GPi 296

UNSPSC

12352005

Hazard Statement

H302-H315-H319

Target

Phosphorylase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Ingliforib.html

Concentration

10mM

Purity

99.07

Solubility

DMSO : 130 mg/mL (ultrasonic)

Smiles

O=C(C(N1)=CC2=C1C=CC(Cl)=C2)N[C@@H](CC3=CC=CC=C3)[C@@H](O)C(N4C[C@@H](O)[C@@H](O)C4)=O

Molecular Formula

C23H24ClN3O5

Molecular Weight

457.91

Precautions

P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501

References & Citations

[1]Tracey WR, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor. Am J Physiol Heart Circ Physiol. 2004 Mar;286 (3) :H1177-84.